Tag Archives: US Bioservices

AmerisourceBergen selected by Deciphera to support QINLOCK (ripretinib)

AmerisourceBergen’s commercialization support services offer an integrated approach to drug launches

AmerisourceBergen’s Hub Services Support XPOVIO Launch

XPOVIO, from Karyopharm Therapeutics, is the first and only prescription medicine approved in the U.S. for the treatment of multiple myeloma

US Bioservices Expands Rare Disease Distribution

Founded in 1994, US Bioservices began as a regional pharmacy focused on infused therapies. Building on a foundation of patient-centered care, it now provides national in-home nursing services and clinical support for thousands of patients with chronic and complex illnesses. US Bioservices was acquired by AmerisourceBergen in 2003. US Bioservices works in collaboration with other […]